BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2968838)

  • 1. Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma.
    Lönn U; Lönn S
    Cancer Res; 1988 Aug; 48(15):4153-7. PubMed ID: 2968838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Mar; 49(5):1085-9. PubMed ID: 2521812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines.
    Lönn U; Lönn S
    Cancer Res; 1986 Aug; 46(8):3866-70. PubMed ID: 2942236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative DNA strand breakage induced by FUra and FdUrd in human ileocecal adenocarcinoma (HCT-8) cells: relevance to cell growth inhibition.
    Yin MB; Rustum YM
    Cancer Commun; 1991 Feb; 3(2):45-51. PubMed ID: 1825284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of floxuridine and 5-fluorouracil in human T-lymphoblast leukemia cells: enhancement by leucovorin.
    Mini E; Moroson BA; Bertino JR
    Cancer Treat Rep; 1987 Apr; 71(4):381-9. PubMed ID: 2950995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
    Taverna P; Rendahl K; Jekic-McMullen D; Shao Y; Aardalen K; Salangsang F; Doyle L; Moler E; Hibner B
    Biochem Pharmacol; 2007 Jan; 73(1):44-55. PubMed ID: 17046720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Schedule-dependent enhancement of the cytotoxicity of fluoropyrimidines to human carcinoma cells in the presence of folinic acid.
    Moran RG; Scanlon KL
    Cancer Res; 1991 Sep; 51(17):4618-23. PubMed ID: 1831402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locus of the interaction among 5-fluorouracil, leucovorin, and interferon-alpha 2a in colon carcinoma cells.
    Houghton JA; Morton CL; Adkins DA; Rahman A
    Cancer Res; 1993 Sep; 53(18):4243-50. PubMed ID: 8364921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
    Ren Q; Van Groeningen CJ; Hardcastle A; Aherne GW; Geoffroy F; Allegra CJ; Johnston PG; Grem JL
    Oncol Res; 1997; 9(2):77-88. PubMed ID: 9167189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma.
    Lönn U; Lönn S
    Cancer Res; 1984 Aug; 44(8):3414-8. PubMed ID: 6430549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Fas-dependent component in 5-fluorouracil/leucovorin-induced cytotoxicity in colon carcinoma cells.
    Tillman DM; Petak I; Houghton JA
    Clin Cancer Res; 1999 Feb; 5(2):425-30. PubMed ID: 10037193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
    Lawrence TS; Heimburger DK; Shewach DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):377-81. PubMed ID: 1991704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of fluoropyrimidine inhibition of cell growth by leucovorin and deoxynucleosides in a human squamous cell carcinoma cell line.
    Chang YM; Bertino JR
    Cancer Invest; 1989; 7(6):557-63. PubMed ID: 2534282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil.
    Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N
    Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased cytotoxicity of 5'-deoxy-5-fluorouridine by prolonged culture with folinic acid.
    Matsuoka H; Furusawa M; Tomoda H; Seo Y; Sugimachi K
    Anticancer Res; 1993; 13(6A):2201-6. PubMed ID: 8297134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha.
    Lönn U; Lönn S
    Radiat Res; 1985 Apr; 102(1):71-5. PubMed ID: 3920725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 dependence of Fas induction and acute apoptosis in response to 5-fluorouracil-leucovorin in human colon carcinoma cell lines.
    Petak I; Tillman DM; Houghton JA
    Clin Cancer Res; 2000 Nov; 6(11):4432-41. PubMed ID: 11106264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.